Article Details
Retrieved on: 2021-06-18 20:18:04
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The German biotech's initial public offering was priced Thursday night at $15 per share, the high end of the expected range.
Article found on: www.cnbc.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here